Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio HoldingsTSE:6092 58 EV-to-EBITDA is 6.45 as of Sep. 14, 2026, which is 62% below its 10-year median of 17.12. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円810.09 (Fairly Valued). The stock has 7 warning signs investors should review. Among 911 Business Services companies, EnBio Holdings ranks better than 56.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, EnBio Holdings's enterprise value is 円13,242 Mil.
EnBio Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,054 Mil. Therefore, EnBio Holdings's EV-to-EBITDA for today is 6.45.
The historical rank and industry rank for EnBio Holdings's EV-to-EBITDA or its related term are showing as below:
TSE:6092'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.38 Med: 17.12 Max: 178.02
Current: 6.45
During the past 13 years, the highest EV-to-EBITDA of EnBio Holdings was 178.02. The lowest was 4.38. And the median was 17.12.
TSE:6092's EV-to-EBITDA is ranked better than 56.31% of 911
companies
in the Business Services industry
Industry Median: 7.36
vs TSE:6092: 6.45
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EnBio Holdings's PE Ratio (TTM) for today is calculated as:
EnBio Holdings's share price for today is 円812.00.
EnBio Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円68.350.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for EnBio Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, GPN: EV-to-EBITDA Comparison
For the Specialty Business Services subindustry, EnBio Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings EV-to-EBITDA vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's EV-to-EBITDA falls into.
EnBio Holdings's current Enterprise Value is 円13,242 Mil.
EnBio Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,054 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings (TSE:6092) has a EV-to-EBITDA of 6.45 as of Sep. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on EnBio Holdings. This is 62% below median its historical median of 17.12. Over the past decade, EnBio Holdings' EV-to-EBITDA has ranged from 4.38 to 178.02. According to the industry distribution chart, EnBio Holdings ranks #398 out of 911 companies in the Business Services industry, placing it in the top 43.7%.
Is EnBio Holdings' EV-to-EBITDA too high?
EnBio Holdings' current EV-to-EBITDA of 6.45 is 62% below median its 10-year median of 17.12. Over the past 10 years, this metric has ranged from a low of 4.38 to a high of 178.02. The Business Services industry median EV-to-EBITDA is 7.36. EnBio Holdings' value of 6.45 is 12.4% below this industry median. Based on the distribution chart, EnBio Holdings ranks #398 out of 911 companies in the Business Services industry, which is above the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' EV-to-EBITDA compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #398 out of 911 companies for EV-to-EBITDA. This puts EnBio Holdings in the upper half of its industry. The industry median EV-to-EBITDA is 7.36. EnBio Holdings' value of 6.45 is 12.4% below this benchmark. Historically, EnBio Holdings' own EV-to-EBITDA has ranged from 4.38 to 178.02 over the past decade. While the company's 10-year median is 17.12 vs. the industry median of 7.36, EnBio Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Business Services company?
The median EV-to-EBITDA among Business Services companies is 7.36, based on 911 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current EV-to-EBITDA of 6.45 is 12.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on EnBio Holdings. For the Business Services industry, the median EV-to-EBITDA is 7.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current EV-to-EBITDA is 6.45, which is 62% below median its own 10-year median of 17.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円810.09, compared to a current price of 円812.00 — trading 0.2% above its estimated fair value. The current EV-to-EBITDA is 6.45, which is 62% below median its 10-year median of 17.12 and 12.4% below the Business Services industry median of 7.36. EnBio Holdings' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current EV-to-EBITDA is 6.45 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be overvalued.
The current stock price of 円812.00 is trading 0.2% above its estimated GF Value™ of 円810.09.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
EV-to-EBITDA: 6.45 (62% below median its 10-year median of 17.12)
GF Value™: 円810.09 vs. price of 円812.00 (0.2% above fair value)
Industry Position: 12.4% below the Business Services median (#398 of 911)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
